T32 Organ Design and Engineering Post-doctoral Training Program (ODET)

The Organ Design and Engineering Post-doctoral Training Program (ODET) is an institutional T32 funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB).

Our goal is to provide multidisciplinary research training to post-doctoral fellows. Individuals accepted into the program will be cross-trained in an area of expertise outside of their primary research field and will be trained at Harvard Medical School and its affiliated hospitals, Boston University, MIT and Tufts University. Individuals accepted into the program will be cross-trained in an area of expertise outside of their primary research field. Working at the intersection of engineering and developmental/ regenerative biology, trainees learn a new language and ultimately develop a common dialect that effectively bridges disciplines. The program utilizes a dual mentor model where fellows spend time in the laboratories of two mentors and are able to benefit from active communication across laboratories, institutions and geographic boundaries.

We are now actively evaluating fellow candidates. We ask you to please let us know if you have any candidates that would be appropriate for the program. Trainees must be US citizens or permanent residents. Candidates may have an MD, PhD or both degrees to qualify.

We will select candidates on a rolling basis.

The program will fund up to two years of training for each trainee. Requirements of the trainees in ODET include:

• Submission of at least one grant application for an individual fellowship in the first year. This serves to expose the fellow to the art of grant writing, frees up slots for additional trainees and provides continued funding after their appointment to the training program ends.
• Participate in a laboratory enrichment experience where the trainee will spend a minimum of 2 months in the laboratory of the co-mentor to have hands-on experience in another discipline. This can be spread out over time and facilitate collaboration between laboratories on a scientific issue important to both laboratories.
• Participate in (a) course(s) or other experience that enriches their knowledge base in the subject of their research and/or the translation/commercialization process of cell-based, nano, regenerative and medical devices therapies. These may be drawn from HMS/MIT and targeted clinical exposure opportunities.
• Submission of an abstract and attendance at one national or international meeting.
• Attend regular meetings where there will be periodic presentations on their research, networking, and exposure to grant writing and other skills important for a successful career as an independent investigator.

Basic Trainee Eligibility

• PhD, MD, MD/PhD, or comparable doctoral degree (see NIH PAR-18-524) upon entering the program.
• The T32 mechanism can support trainees who are either US citizens or permanent residents.
• Our goal is to recruit a truly diverse T32 trainee pool; applicants from diverse backgrounds are encourage to apply.

Application

Submission Materials:

• Please use this cover sheet
• 2-page (maximum) personal statement that describes the applicant’s: [1] background; [2] interest in T32 program; [3] fellowship training goals; [4] choice of primary T32 mentor*; [5] career goals.
• CV
• 2 letters of recommendation
• 1-2 selected research publications for which candidate is an author (if available), URL is sufficient
• Please complete demographic information form
• Additional information may be requested after initial application materials are received (e.g., transcripts)

Please submit these materials or any questions to Kerry Conway (Grant Administrator) at: bwhodet@partners.org

T32 Faculty

• Elena Aikawa, M.D., Ph.D., Professor, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital
• Natalie Artzi, Ph.D., Assistant Professor, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Mercedes Balcells-Camps, Ph.D, Principal Research Scientist, Institute for Medical Engineering & Science, Massachusetts Institute of Technology
• Sangeeta Bhatia, M.D., Ph.D., Professor, Institute for Medical Engineering & Science, Massachusetts Institute of Technology
• Joseph F. Bonventre, M.D., Ph.D., Professor, Division of Renal Medicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Martha Bulyk, Ph.D., Professor, Division of Genetics, Department of Medicine, Brigham and Women's Hospital
• Fernando Camargo, Ph.D., Professor, Division of Hematology/ Oncology, Department of Pediatrics, Boston Children’s Hospital
• Elliot L. Chaikof, M.D., Ph.D., Professor, Department of Surgery, Beth Israel Deaconess Medical Center
• Christopher Chen, M.D., Ph.D., Professor, Department of Biomedical Engineering, Boston University
• Philip A. Cole, M.D., Ph.D., Professor, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
• April Craft, Ph.D., Assistant Professor, Orthopedic Surgery
• Elazer Edelman, M.D., Ph.D., Professor, Institute for Medical Engineering & Science, Massachusetts Institute of Technology
• Ryan Flynn, M.D., Ph.D., Assistant Professor, Division of Hematology/ Oncology, Department of Pediatrics, Boston Children's Hospital
• Natasha Frank, M.D, Associate Professor, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
• Guillermo Garcia-Cardena, Ph.D., Associate Professor, Department of Pathology, Brigham and Women’s Hospital
• Vadim Gladyshev, Ph.D., Professor, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
• Ya-Chieh Hsu, Ph.D., Professor, Department of Stem Cell and Regenerative Biology, Harvard University
• Donald E. Ingber, M.D., Ph.D., Professor, Wyss Institute
• Rudolf Jaenisch, M.D, Professor, Jaenisch Lab, Whitehead Institute
• Roger Kamm, Ph.D., Professor, Department of Mechanical Engineering – MechE, Massachusetts Institute of Technology
• David L. Kaplan, Ph.D., Professor, Department of Biomedical Engineering, Tufts University
• Jeffrey M. Karp, Ph.D., Professor, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital
• Luke Lee, Ph.D., Professor, Division of Renal Medicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Richard T. Lee, M.D, Professor, Department of Stem Cell and Regenerative Biology, Harvard University
• Dario Lemos, Ph.D., Assistant Professor, Division of Renal Medicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Bruce D. Levy, M.D., Professor, Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women’s Hospital
• Jennifer A. Lewis, Ph.D., Professor, School of Engineering and Applied Sciences, Harvard University
• Joseph Loscalzo, M.D., Ph.D., Professor, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital
• L. Mahadevan, Ph.D., Professor, School of Engineering and Applied Sciences, Harvard University
• Kara McKinley, Ph.D., Assistant Professor, Department of Stem Cell and Regenerative Biology, Harvard University
• David J. Mooney, Ph.D., Professor, School of Engineering and Applied Sciences, Harvard University
• Kevin "Kit" Parker, Ph.D., Professor, School of Engineering and Applied Sciences, Harvard University
• Olivier Pourquié, Ph.D., Professor, Department of Pathology, Brigham and Women’s Hospital
• Jonathan Seidman, Ph.D., Professor, Department of Genetics, Harvard Medical School
• Hadi Shafiee, Ph.D., Assistant Professor, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Richard Sherwood, Ph.D., Assistant Professor, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
• Su Ryon Shin, Ph.D., Assistant Professor, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital
• Ramesh Shivdasani, M.D., Ph.D., Professor, Medical Oncology, Dana-Farber Cancer Institute
• Michael Todd Valerius, Ph.D., Instructor, Division of Renal Medicine, Department of Medicine, Brigham and Women’s Hospital
• Aristidis Veves, M.D., MSc., DSc, Professor, Department of Surgery, Beth Israel Deaconess Medical Center"
• Catherine Ju-Ying Wu, M.D., Professor, Medical Oncology, Dana-Farber Cancer Institute
• Qiaobing Xu, Ph.D., Professor, Department of Biomedical Engineering, Tufts University
• Seung-Schik Yoo, Ph.D., Associate Professor, Department of Radiology, Brigham and Women’s Hospital
• Yu Shrike Zhang, Ph.D., Assistant Professor, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital

Questions?

Please contact Kerry Conway (Grant Administrator) at: bwhodet@partners.org